AI-Powered Summary
Market Context
Top Queries
More News
Explore Prysm Tools
Related Stories
Bafna Pharma Files Certificate Under SEBI (Depositories) Regulations, Q3FY26
Bafna Pharmaceuticals Limited
January 9, 2026, 09:57 AM
Top Queries to Ask About Bafna Pharmaceuticals Limited
InstantThinking to buy or sell Bafna Pharmaceuticals Limited? Ask AI before you act.
Trusted by 5,000+ users
More Details on This News
Bafna Pharmaceuticals Limited has submitted a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025.
The certificate was received from M/s. Cameo Corporate Services Limited, the company's Registrar and Share Transfer Agent (RTA).
Cameo Corporate Services Limited confirmed that securities received from depository participants for dematerialisation during the quarter were processed and listed on the stock exchanges. They also confirmed that the security certificates received for dematerialisation were mutilated, cancelled, and the depositories were substituted in the register of members as the registered owner within the stipulated time.
See What Deep Dive Gives You — in Seconds
“what happens when you click
Deep Dive “
“what happens when you click Deep Dive “
Instant AI Summary - “Get clean, noise-free earnings breakdowns.”
PDF Insights - “Download detailed, AI-generated reports.”
Metrics Explained -“Key ratios & trends explained in simple language.”
Want to know if this news pushes your stock up or down?
Just tap
More News on Bafna Pharmaceuticals Limited
Analyze Bafna Pharmaceuticals Limited